Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Curasight gears up for phase II study in prostate cancer

Following the Curium deal this spring, Curasight has now submitted a clinical trial application and selected a CRO to carry out a phase II trial with uTRACE. The trial intends to evaluate the uTRACE for the diagnosis of prostate cancer patients. BioStock contacted Curasight CEO Ulrich Krasilnikoff to learn more.Read the full article at biostock.se: https://www.biostock.se/en/2023/12/curasight-gears-up-for-phase-ii-study-in-prostate-cancer/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Alleima receives a major order for steam generator tubes in the Nuclear segment

Alleima has received a major order for steam generator tubes, to a total value of approximately SEK 220 million. The receipt of this order is a clear proof of Alleima’s strong position in the Nuclear segment.The order from one of the world’s leading suppliers of nuclear power equipment is classified as a major order (i.e. above SEK 200 million) and was booked in the fourth quarter of 2023. The order will be reported in the Tube division and deliveries are scheduled for the second half of 2025. “We see great potential for growth in the Nuclear segment. Our addressable market in the

EcoVadis ranks Outokumpu among the top 1% of companies assessed with a Platinum rating

Outokumpu Oyj Press release Dec 22, 2023 at 10.00 am EETEcoVadis ranks Outokumpu among the top 1% of companies assessed with a Platinum rating  Outokumpu, the global leader in sustainable stainless steel, has received the highest Platinum level recognition from the sustainability rating platform EcoVadis. Today, Outokumpu ranks among the top 1% of more than 100,000 companies assessed based on its strong performance in sustainability. This is not the first time Outokumpu receives the Platinum recognition, but this year, Outokumpu scored its all-time high points. 

ANNOUNCEMENT OF THE NAV OF P CAPITAL PARTNERS IV B

PRESS RELEASE Stockholm, 22 December 2023 Today the Net Asset Values of the P Capital Partners IV B participation loan debentures are being announced. At the close of business on 21 December 2023, the Net Asset Value of the series A1 participation loan debentures amounted to EUR 84.39 each, and the Net Asset Value of the series B participation loan debenture amounted to EUR 844.63 each.   The Net Asset Value of P Capital Partners IV B participation loan debentures is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease.   The

Saab receives order from NATO for RBS 70 Bolide missiles

Saab has received an order for RBS 70 Bolide missiles from the NATO Support and Procurement Agency (NSPA). The order value amounts to SEK 350 million and deliveries will take place during 2027.“Through the order from the NSPA, we see NATO countries continued interest in our missile systems. This order is proof of their trust in our knowledge and in the RBS 70 system,” says Görgen Johansson, head of Saab’s business area Dynamics.  The RBS 70 system has an installed base in more than 19 countries, with 1,600 RBS 70 systems and more than 18,000 missiles delivered. The Bolide missile is the

DNB Bank ASA shall buy back up to 0.75 percent of the company’s own shares

DNB Bank ASA has decided to initiate a share buy-back programme comprising up to 0.75 percent of the company’s own shares, which represents a total of 11,569,599 shares. The buy-back programme was adopted based on an authorisation given by the Annual General Meeting held on 25 April 2023. The Financial Supervisory Authority of Norway has approved the buy-back programme, on the condition that the total buy-backs do not reduce the company’s own funds by more than NOK 2.5 billion. The purpose of the buy-back programme is to optimise the company’s capital structure, by reducing the common

BioStock: CombiGene comments on Eurostars funding

CombiGene, together with its Danish partner Zyneyro, has received welcome financial support of 8,6 million SEK from Eurostars for the continued development of the peptide COZY1, a drug candidate for the treatment of severe chronic pain conditions. BioStock reached out to CombiGene’s CEO Peter Ekolind for a comment.Read the full interview with Peter Ekolind at biostock.se: https://www.biostock.se/en/2023/12/combigene-comments-on-eurostars-funding/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Kiilto Ventures invests in RECOMA, a Swedish startup specializing in 100% recycled construction boards

Kiilto Ventures invests in RECOMA , a Swedish startup that turns packaging waste into low-carbon, fully circular construction boards that can replace traditional materials, such as plywood, drywall, and oriented strand board (OSB), without extra cost or effort for builders. And because no virgin materials get added during the manufacturing process, operational waste and water use achieve net-zero.The construction industry is one of the largest contributors to carbon emissions and waste generation. In Sweden alone, the construction industry accounts for 20% of total

BioStock: Can AI help solve cancer? – Evaxion Biotech talks AI, cancer and partnerships

At the end of August, Evaxion Biotech announced a change in top management, hiring Christian Kanstrup as CEO. Kanstrup stopped by the BioStock Studio to tell us about his vision for Evaxion and how he plans to implement that vision.Watch the interview with Christian Kanstrup at biostock.se: Can AI help solve cancer? - Evaxion Biotech talks AI, cancer and partnerships - BioStock This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Rejlers signs two-year framework agreement with Öresundskraft

Rejlers has signed a framework agreement with Öresundskraft AB for technical consulting services in electricity, district heating and cooling. The agreement is valid for two years with the possibility of extension until 2032.With its 125,000 customers, Öresundskraft is one of Sweden's ten largest energy companies. The product range mainly includes the production and distribution of electricity, district heating, biogas and district cooling, but also broadband, IoT and various types of energy services. The new framework agreement covers continuous call-offs in twelve sub-areas regarding

Skanska divests the new municipal building in Enköping, Sweden, to Vacse for about SEK 250M

Skanska divests Enköping's new municipal building, which is under construction, to Vacse for approximately SEK 250M. The sale will be recorded by Skanska commercial property development in the fourth quarter of 2023.The new municipal building, designed by the architectural firm CF Møller, is being built on the property where the old municipal building was situated. The building will be four stories high and have a gross area of approximately 5,400 square meters. The office building will be the workplace for approximately 450 of the municipality's employees in an activity-based office

Nordhealth AS - Primary insider notices

Helsinki, Finland, 22 December 2023: Charles MacBain, the CEO and a primary insider of Nordhealth AS (the "Company"), has today sold 1,650,316 class A shares in the Company at a price of NOK 21.34 per share, in two separate transactions to family members who have agreed to vote and dispose of the shares with Charles MacBain. Following the transactions, Charles MacBain owns 5,773,507 class A shares in the Company. In addition, he holds 24,289,319 class B shares, in total 30,062,826 shares. Please refer to the attached notifications in accordance with the Market Abuse Regulation article

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseDecember 22, 2023, at 9.30 am EETRepurchase of Outokumpu’s own shares On December 21, 2023, Outokumpu has completed repurchases its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|CEUX |52,623 |4.4572

YIT begins construction of health and wellbeing centre in Kamppi, central Helsinki

YIT Corporation Investor News 22 December 2023 at 9.30 a.m.YIT begins construction of health and wellbeing centre in Kamppi, central Helsinki YIT has signed a cooperative project management contract for the Keskusta health and wellbeing centre project to be built for the use of City of Helsinki. The contract will be signed with KOy Helsingin Toimitilat. For YIT, the value of the implementation phase of the construction contract, which is now starting, is approximately EUR 90 million. It will be recorded in the order book for the fourth quarter of the year. Work on the implementation

Valmet to strengthen its wood handling technology and services in South America by acquiring Demuth

Valmet Oyj’s press release on December 22, 2023 at 9:30 a.m. EETValmet has on December 21, 2023, entered into an agreement to acquire Demuth, a Brazilian company specializing in wood handling solutions for the pulp industry. This acquisition will strengthen Valmet’s wood handling technology offering and services presence in South America.   The value of the acquisition will not be disclosed. The acquisition is subject to relevant competition authority approvals and is estimated to be completed during the second or third quarter of 2024. Demuth is a family-owned company established in

Ruukki Construction concludes cost-adjustment program

SSAB's subsidiary Ruukki Construction has completed the cost-adjustment program announced in June 2023. The company-wide adjustment measures resulted in a total reduction of 182 jobs in Ruukki's operating countries. The measures will result in annual cost savings of approximately EUR 15 million.The adjustment program initiated by Ruukki Construction in June 2023 has completed. The changes affected all the company’s businesses and operating countries and were aimed at aligning operations to lower demand  on the construction market and achieving cost savings of approximately EUR 15 million.

NYAB Oyj - Managers' Transactions

NYAB PlcMANAGERS' TRANSACTIONS22 December 2023NYAB Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: PM Ruukki OyPosition: Closely associated person(X) Legal person (1):Person Discharging Managerial Responsibilities In IssuerName: Markku KankaalaPosition: Member of the BoardIssuer: NYAB OyjLEI: 743700UX7WTIOT3QO547Notification type: INITIAL NOTIFICATIONReference number: 46763/5/4 ____________________________________________Transaction date: 2023-12-21Outside a trading venue

NYAB Oyj - Managers' Transactions

NYAB PlcMANAGERS' TRANSACTIONS22 December 2023 at 09:05NYAB Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Johan LarssonPosition: Chief Executive Officer Issuer: NYAB OyjLEI: 743700UX7WTIOT3QO547Notification type: INITIAL NOTIFICATIONReference number: 46760/4/6 ____________________________________________Transaction date: 2023-12-19Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)Instrument type: SHAREISIN: FI4000153515Nature of transaction: ACQUISITION  Transaction details(1):

RaySearch releases RayStation 2024A

RaySearch Laboratories AB (publ) announces the launch of RayStation®* 2024A, the latest version of the company’s comprehensive treatment planning system. The new version brings several enhancements to important clinical workflows.RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs. The new version of the treatment planning system adds the possibility to select fixation and support devices per plan and sub-plan. This adds improved flexibility when making combined treatment plans for a patient, for example photon-proton

NYAB approves revised long-term financial targets and a new strategic plan for 2024-2026 (inside information)

NYAB PlcCOMPANY ANNOUNCEMENT22 December 2023 at 09:02NYAB approves revised long-term financial targets and a new strategic plan for 2024–2026 (inside information) NYAB’s Board of Directors has approved a new strategic plan for 2024–2026. NYAB’s vision is to become the preferred partner in building a better future for generations to come, as well as to be the first-choice workplace for dedicated professionals. In connection with the strategic plan, NYAB has revised its long-term financial targets. The new long-term financial targets are: · annual revenue growth exceeding 10%

Notice of Results

22 December 2023   Tap Global Group plc (“Tap Group” or the “Company”)   Notice of Results   Tap Global Group Plc  (AQSE: TAP), the regulated cryptocurrency app (via its wholly owned operating business Tap Global Limited) bridging the gap between traditional finance and blockchain technology, is pleased to confirm that the Company will publish its financial results for the year ended 30 June 2023 on 28 December 2023.   Enquiries:    Tap Global Group Plc  Via Vigo ConsultingDavid Carr, Chief Executive  Officer

SAS files monthly operating reports with U.S. court and announces certain financial information for the Group

SAS AB (“SAS” or the “Company”) and each of its subsidiaries that are subject to the voluntary chapter 11 process in the U.S. will shortly file monthly operating reports, containing certain financial information for the period of November 1, 2023 to November 30, 2023 with the U.S. Bankruptcy Court for the Southern District of New York (the “Court”). All SAS companies that are subject to the voluntary chapter 11 process are each required to file operating reports with the Court on a monthly basis. The financial information contained in the monthly operating reports includes items such as cash

CapMan Plc’s Notice of Extraordinary General Meeting

CapMan Plc Stock Exchange Release  22 December 2023 9:00 a.m. EET   CapMan Plc’s Notice of Extraordinary General Meeting  Notice is given to the shareholders of CapMan Plc (“CapMan” or the “Company”) of the Extraordinary General Meeting (the “General Meeting”) to be held on 18 January 2024 at 10:00 a.m. (EET) at Borenius Attorneys, Eteläesplanadi 2, 00130 Helsinki, Finland. The reception of persons who have registered for the General Meeting and the distribution of voting tickets will start at 9:30 a.m. (EET).  CapMan provides the option for shareholders to exercise their

Wainua (eplontersen) granted first US FDA approval

22 December 2023 Wainua (eplontersen) granted first-ever regulatory approval in the US for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis US FDA approval based on NEURO-TTRansform Phase III results showing Wainua demonstrated consistent and sustained benefit improving neuropathy impairment and quality of life Additional regulatory reviews underway in rest of world AstraZeneca and Ionis' Wainua (eplontersen) has been approved in the US for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults,

There are no items matching the current filter
There are no more items matching the current filter
Back to top